As of 2026-06-23, the EV/EBITDA ratio of Global Blood Therapeutics Inc (GBT) is -16.85. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GBT's latest enterprise value is 4,942.22 mil USD. GBT's TTM EBITDA according to its financial statements is -293.25 mil USD. Dividing these 2 quantities gives us the above GBT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.8x - 22.1x | 14.8x |
| Forward P/E multiples | 13.9x - 41.5x | 27.4x |
| Fair Price | (65.16) - (100.71) | (96.46) |
| Upside | -195.1% - -247.0% | -240.8% |
| Date | EV/EBITDA |